Role of omalizumab in a patient with hyper-IgE syndrome and review dermatologic manifestations.
Leena Chularojanamontri(Siriraj Hospital), Nisa Kiewjoy, Saranjit Wimoolchart, Kanokvalai Kulthanan(Siriraj Hospital), Papapit Tuchinda(Siriraj Hospital)
PubMed
December 1, 2009
Cited by 42
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Urticaria
|Nature Reviews Disease Primers|2022|368
The global burden of chronic urticaria for the patient and society*
|British Journal of Dermatology|2020|351
Chronic idiopathic urticaria: prevalence and clinical course
|The Journal of Dermatology|2007|184